Literature DB >> 31279729

Integrating nanomedicine into clinical radiotherapy regimens.

Allison N DuRoss1, Megan J Neufeld1, Shushan Rana2, Charles R Thomas2, Conroy Sun3.   

Abstract

While the advancement of clinical radiotherapy was driven by technological innovations throughout the 20th century, continued improvement relies on rational combination therapies derived from biological insights. In this review, we highlight the importance of combination radiotherapy in the era of precision medicine. Specifically, we survey and summarize the areas of research where improved understanding in cancer biology will propel the field of radiotherapy forward by allowing integration of novel nanotechnology-based treatments.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Chemoradiotherapy; Dosing; Drug delivery; Multimodal therapy; Nanoparticles; Radiation therapy

Mesh：

Year:  2019        PMID： 31279729      PMCID： PMC6745263          DOI： 10.1016/j.addr.2019.07.002

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN： 0169-409X            Impact factor:   15.470


  184 in total

1.  Three-Arm Randomized Trial of Sodium Alginate for Preventing Radiation-Induced Esophagitis in Locally Advanced Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: The OLCSG1401 Study Protocol.

Authors:  Kiichiro Ninomiya; Eiki Ichihara; Katsuyuki Hotta; Naoyuki Sone; Toshi Murakami; Daijiro Harada; Isao Oze; Toshio Kubo; Hisaaki Tanaka; Shoichi Kuyama; Daizo Kishino; Akihiro Bessho; Shingo Harita; Kuniaki Katsui; Mitsune Tanimoto; Katsuyuki Kiura
Journal:  Clin Lung Cancer       Date:  2016-10-19       Impact factor: 4.785

2.  X-Ray responsive nanoparticles with triggered release of nitrite, a precursor of reactive nitrogen species, for enhanced cancer radiosensitization.

Authors:  Fang Liu; Junzhe Lou; Dimitre Hristov
Journal:  Nanoscale       Date:  2017-10-05       Impact factor: 7.790

3.  Radiation-guided drug delivery to mouse models of lung cancer.

Authors:  Ghazal Hariri; Heping Yan; Hailun Wang; Zhaozhong Han; Dennis E Hallahan
Journal:  Clin Cancer Res       Date:  2010-08-27       Impact factor: 12.531

4.  Significance of blood vessel leakiness in cancer.

Authors:  Donald M McDonald; Peter Baluk
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

Review 5.  Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies.

Authors:  Alberto Gabizon; Hilary Shmeeda; Yechezkel Barenholz
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

6.  EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy.

Authors:  Hua Jin; Jiang Pi; Yue Zhao; Jinhuan Jiang; Ting Li; Xueyi Zeng; Peihui Yang; Colin E Evans; Jiye Cai
Journal:  Nanoscale       Date:  2017-11-02       Impact factor: 7.790

7.  Acidic extracellular microenvironment and cancer.

Authors:  Yasumasa Kato; Shigeyuki Ozawa; Chihiro Miyamoto; Yojiro Maehata; Atsuko Suzuki; Toyonobu Maeda; Yuh Baba
Journal:  Cancer Cell Int       Date:  2013-09-03       Impact factor: 5.722

Review 8.  An Overview on Radiotherapy: From Its History to Its Current Applications in Dermatology.

Authors:  Serena Gianfaldoni; Roberto Gianfaldoni; Uwe Wollina; Jacopo Lotti; Georgi Tchernev; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2017-07-18

9.  Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).

Authors:  M G Fury; E J Sherman; S S Rao; S Wolden; S Smith-Marrone; B Mueller; K K Ng; P R Dutta; D Y Gelblum; J L Lee; R Shen; S Kurz; N Katabi; S Haque; N Y Lee; D G Pfister
Journal:  Ann Oncol       Date:  2014-02-03       Impact factor: 32.976

Review 10.  Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions.

Authors:  Yifan Wang; Weiye Deng; Nan Li; Shinya Neri; Amrish Sharma; Wen Jiang; Steven H Lin
Journal:  Front Pharmacol       Date:  2018-03-05       Impact factor: 5.810
View more
  4 in total

Review 1.  Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.

Authors:  Frederik Soetaert; Preethi Korangath; David Serantes; Steven Fiering; Robert Ivkov
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

2.  Intelligent design of polymer nanogels for full-process sensitized radiotherapy and dual-mode computed tomography/magnetic resonance imaging of tumors.

Authors:  Changchang Zhang; Wenzhi Tu; Xuming Chen; Bing Xu; Xin Li; Chaolei Hu; Mingwu Shen; Shaoli Song; Chunjuan Jiang; Shengyu Yao; Andrij Pich; Yong Liu; Xiangyang Shi
Journal:  Theranostics       Date:  2022-04-18       Impact factor: 11.600

3.  Tumor-Targeted Injectable Double-Network Hydrogel for Prevention of Breast Cancer Recurrence and Wound Infection via Synergistic Photothermal and Brachytherapy.

Authors:  Yuanhao Wu; Yuan Yao; Jiamin Zhang; Han Gui; Jinjian Liu; Jianfeng Liu
Journal:  Adv Sci (Weinh)       Date:  2022-06-25       Impact factor: 17.521

4.  Exosomes derived from γδ-T cells synergize with radiotherapy and preserve antitumor activities against nasopharyngeal carcinoma in immunosuppressive microenvironment.

Authors:  Xiwei Wang; Yanmei Zhang; Xiaofeng Mu; Chloe Ran Tu; Yuet Chung; Sai Wah Tsao; Godfrey Chi-Fung Chan; Wing-Hang Leung; Yu-Lung Lau; Yinping Liu; Wenwei Tu
Journal:  J Immunother Cancer       Date:  2022-02       Impact factor: 13.751
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.